Acrocyanosis of peripheral vascular origin
Specialty: Cardiovascular.
Why it occurs
- Persistent arteriolar spasm and dilation of peripheral capillaries and venules
- Small vessel vasculitis (systemic lupus erythematosus, systemic sclerosis)
- Presence of cryoglobulins or cryoagglutinins of clinical importance
- Distal arterial occlusive disease of the extremities
- Paraneoplastic vascular syndrome secondary to hematological or solid visceral neoplasms
Initial workup
General analysis that includes complete blood count, erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), immunological panel (antinuclear antibodies (ANA), anti-DNA antibodies, rheumatoid factor), determination of cryoglobulins, cryoagglutinins and antiphospholipid antibodies; Periungual capillaroscopy to evaluate the density, caliber and distortion of dermal capillaries; Arterial Doppler ultrasound of distal vessels to rule out occlusive disease of large and medium vessels.
red flags
Persistent and symmetrical bluish or purple discoloration of the fingers, toes or face that is not associated with paroxysmal pain or previous pallor (different from Raynaud's phenomenon), accompanied by painful ischemic periungual ulcers, necrosis of distal soft tissues (dry digital gangrene), loss of tactile or painful sensation, asymmetry or abolition of arterial pulses ipsilateral, or severe systemic symptoms such as prolonged fever, arthritis, photosensitivity or hematuria. Requires immediate specialized evaluation to prevent irreversible loss of digital tissues.
Standard management
- Nifedipine — extended-release dihydropyridine calcium antagonist to induce peripheral arteriolar vasodilation; 30 to 60 mg once daily orally, monitoring for the development of hypotension or headache
- Sildenafil — phosphodiesterase-5 inhibitor indicated in refractory cases or secondary to systemic sclerosis to improve distal tissue perfusion; 20 mg twice daily orally
- Pentoxifylline — hemorheological agent to improve the deformability of erythrocytes and facilitate microflow; 400 mg three times a day orally
- Iloprost (synthetic prostacyclin analog indicated in severe digital ischemia refractory to oral therapy; slow intravenous infusion of 0.5 to 2.0 ng/kg/min for 6 hours a day for 3 to 5 days, in a hospital setting).
Educational guidance for study. It is NOT a prescription recommendation. The actual choice depends on the cause, the patient, and current guidelines.
- Area
- Cardiovascular
- Listed causes
- 5
- Treatment options
- 4